Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

BACKGROUND: Cisplatin-based combination chemotherapy is standard first-line treatment for patients with advanced urothelial carcinoma (UC). Molecular profiling studies reveal that the PI3K/AKT/mTOR pathway is altered in a significant percentage of UCs. OBJECTIVE: We conducted a phase I trial to eval...

詳細記述

保存先:
書誌詳細
出版年:Bl Cancer
主要な著者: Abida, Wassim, Milowsky, Matthew I., Ostrovnaya, Irina, Gerst, Scott R., Rosenberg, Jonathan E., Voss, Martin H., Apolo, Andrea B., Regazzi, Ashley M., McCoy, Asia S., Boyd, Mariel E., Bajorin, Dean F.
フォーマット: Artigo
言語:Inglês
出版事項: IOS Press 2016
主題:
Research Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4927849/
https://ncbi.nlm.nih.gov/pubmed/27376132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-150038
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料